Longevity Ledger

Supplements & Resources

NMN

2/5 Limited

NAD+ precursor marketed for longevity.

Why this evidence score

Human outcome data are limited; regulatory status varies.

How we score

Pros

  • Early human studies
  • Popular

Cons

  • No proven clinical benefit
  • Regulatory uncertainty
Price
Moderate; check site
Available in
Global
Visit NMN

We may earn a commission if you buy through links on this site. It never changes our scores.

Longevity Ledger provides information, not medical advice. Consult a licensed clinician before changing medication, hormones, supplements or training. Some links are affiliate links; see our affiliate disclosure.